We studied the effects of natural and recombinant human IL-2 (rIL-2) on secretion of prostacyclin (PGI2), vWf, and tissuetype plasminogen activator (tPA). IL-2 elicited a steady increase in PGI2 synthesis by cultured human umbilical vein endothelial cells (HUVECS) and bovine aortic endothelial cells but had no effect on vWf or tPA. Both purified natural IL-2 (nIL-2) and rIL-2 induced significant PGI2 synthesis. Substitution of the cysteine residue at position 125 of rIL-2 with serine or alanine led to loss of PGI2-stimulatory activity in HUVECS without affecting thymidine incorporation in lymphocytes. HPLC analysis of arachidonate metabolites detected predominantly 6 keto-PGFI, (6KPGFIa) peak. Treatment of cultured endothelial cells with cycloheximide and actinomycin D resulted in inhibition of 6KPGFi,,a synthesis. The Western blot using a polyclonal antibody against PGH synthase revealed an increment in the 70-kD subunit of PGH synthase by nIL-2 and rIL-2, but not by alanine-substituted rIL-2. We conclude that IL-2 stimulates sustained PGI2 production by a mechanism that includes the de novo synthesis of PGH synthase. This mechanism for regulating AA metabolism probably has important physiologic implications.
Introduction
IL-2 is a 1 5-kD glycoprotein secreted by lymphocytes. It was first described as a lymphokine capable of promoting the long-term growth of activated T lymphocytes in vitro (1, 2) . It has subsequently been shown to modulate the functions of several subtypes of lymphocytes including cytotoxic T cells (3, 4) , natural killer cells (5, 6) , activated B cells (7, 8) , and lymphokine-activated killer cells (9, 10) . The biological activity of IL-2 is, however, not entirely limited to lymphocytes. Previous studies from our laboratory have shown that purified natural IL-2 (nIL-2)' has a significant stimulatory effect on prostacy-1. Abbreviations used in this paper: BAECS, bovine aorta endothelial cells; CTC, cultured T cells; EC, cultured endothelial cells; G rIL-2, glycosylated rIL-2; HETE, hydroxyeicosatetraenoic acid; clin (PGI2) synthesis by bovine endothelial cells (11) . In an effort to elucidate the mechanism by which IL-2 elicits sustained stimulation of eicosanoid synthesis, we investigated the effects of recombinant (r) and (n)IL-2 on endothelial cell AA metabolism as well as on the release of vWf and tissue-type plasminogen activator (tPA) from cultured human endothelial cells (EC). Our data indicate that IL-2 induces de novo synthesis of PGH synthase. By contrast, it has no effect on vWf or tPA generation.
Methods
Materials. Human nIL-2 was obtained from Cellular Products, Inc. (Buffalo, NY). Nonglycosylated rIL-2 (NG rIL-2), natural sequence analogue expressed in Escherichia coli, was from Amgen Biologicals (Thousand Oaks, CA). It has the entire 133 amino acids with addition of a methionine residue at the amino terminus. Two NG rIL-2 preparations that had a substitution ofthe cysteine at amino acid residue 125 (Cys'25) were obtained. One NG rIL-2 from Amgen Biologicals had substituted Cys'25 with alanine, while the other preparation from Cetus Corp. (Berkeley, CA) had substituted it with serine. The first alanine residue at the NH2 terminus was also absent in the latter compound. Glycosylated rIL-2 (G rIL-2) expressed in yeast containing0. 1% Triton X-100, 1 mM PMSF, 0.01% EDTA, and 0.03% leupeptin. The lysates were boiled for 3 min and centrifuged at 15,000 rpm for 10 min in an Eppendorf microfuge. The supernatant that contained the solubilized PGH synthase was concentrated and 50 jd of the sample was applied to an 8% SDS polyacrylamide gel as described by Laemmli ( 18). After electrophoresis, the proteins were electrophoretically transferred to nitrocellulose sheets at 0.2 A for 4 h in 25 mM Tris, 190 mM glycine, and 20% (vol/vol) methanol. The blot was saturated with 5% BSA for 3 h and then the nitrocellulose papers were incubated with the anti-PGH synthase antibody (10 Ag/ml) at room temperature overnight. After washing, the papers were treated with goat anti-rabbit IgG conjugated with horseradish peroxidase (1:2,000; Bio-Rad Laboratories, Richmond, CA). The blots were treated with 4-chloro-l-naphthol (Bio-Rad Laboratories) for color development and visualization.
Statistical analysis. Data generated from multiple experiments were expressed as mean±SD. The t test was used to determine whether differences were statistically significant.
Results
The effects of nIL-2 and rIL-2 on HUVEC PGI2 synthesis and CTC thymidine incorporation were evaluated concurrently using the identical IL-2 preparations freshly obtained. The nIL-2 exhibited the expected stimulatory activities on lymphocyte thymidine uptake (Fig. 1A) and HUVEC PGI2 synthesis ( Fig. 2A) . The NG rIL-2 as well as its alanine and serine analogues enhanced thymidine incorporation (Fig. 1, B and C). The order of potency was NG rIL-2 > alanine analogue > serine analogue. G rIL-2, on the other hand, had no stimulating effect (Fig. 1B) . By contrast, NG rIL-2 and G rIL-2 stimulated HUVEC PGI2 synthesis while the substituted NG rIL-2s (alanine or serine substitution) were unable to stimulate PGI2 production (Fig. 2, B and D) . Stimulation of the HUVECS by NG rIL-2 and G rIL-2 was both time dependent and concentration dependent. 1 U/ml of NG rIL-2 increased 6KPGFIa levels 4 h after its addition to HUVECS (Fig. 2B) while 50 U/ml of G rIL-2 was required to elicit an increase in 6KPGF,a (Fig. 2E) . The time course of stimulation also differed between these two recombinant compounds (Fig. 3) .
Generally, stimulation by NG rIL-2 reached a maximum around 12 h after the addition of IL-2 although in some experiments 6KPGFIa generation continued to increase after 12 h. Stimulation by G rIL-2, on the other hand, always gave a steady rate of 6KPGF1, increase over the entire 24 h investigated (Fig. 3) . BAECS released a large quantity of 6KPGF1, when stimulated with nIL-2 (Table I) . Their response to rIL-2 was not as substantial. However, the G rIL-2 appeared to be more potent than the NG rIL-2 (Table I) .
To determine whether other arachidonate metabolites were also stimulated, we analyzed the eicosanoids by reversephase HPLC. The HPLC profile of BAECS treated with IL-2 for 10 min (Fig. 4A) treated with medium without IL-2 for 10 min (data not shown). Essentially only the AA peak was noticeable. By contrast, BAECS treated with IL-2 for 24 h yielded a prominent 6KPGF1,, peak accompanied by apparent TXB2, PGF2a, PGE2, HHT, 15-HETE, and AA peaks (Fig. 4B) while the 24-h medium control showed a small 6KPGFIa peak and a prominent AA peak (Fig. 4C ). BAECS incubated with 10 ,uM ionophore A23187 for 30 min exhibited a large 6KPGFia peak (Fig. 4D) (Table II) . Actinomycin D, a specific inhibitor of RNA synthesis, also exerted a dose-related inhibition of PGI2 synthesis (Table II) 5A, the polyclonal antibody recognized the 70-kD subunit of purified ram seminal vesicle PGH synthase in a dose-related manner. A protein migrating coincident with the purified PGH synthase (70 kD) was present in the HUVECS incubated with medium alone (Fig. 5 B, lane 3) . This band was enhanced by treatment of HUVECS with 50 U/ml NG rIL-2 for 2 h (Fig.  5 B, lane 2) and the enhanced effect of IL-2 was abolished by cycloheximide ( Fig. 5 B, lane 4) . Fig. 6 shows the 70-kD band in HUVECS incubated 2-4 h with medium containing various preparations of rIL-2. HUVECS treated with medium alone expressed the 70-kD band, and the intensity of the band appeared increased from 2-4 h (lanes 1 and 6) . The 70-kD band was enhanced by 2-h treatment with G rIL-2 (lane 3) and NG rIL-2 (lane 5), and further enhanced at 4 h (G rIL-2, lane 7; NG rIL-2, lane 9). The alanine-substituted NG rIL-2 had no apparent enhancing effect on the 70-kD band at either 2 or 4 h of incubation (lanes 4 and 8) . The polyclonal antibody also recognized the 70-kD subunit of BAECS incubated with medium in the absence and presence of IL-2. Similar to the HUVEC data, the 70-kD band was increased by nIL-2 in a time-related fashion (Fig. 7) .
Experiments were then performed to determine whether physiologically important proteins such as vWf and tPA were also stimulated by IL-2. HUVECS were treated with rIL-2, and medium was removed at various time periods and assayed for vWf and tPA by highly specific ELISAs. 6KPGF1a assays were concurrently performed. Despite a time-related increment in 6KPGFIa levels after IL-2 stimulation, the levels of vWf and tPA in the IL-2-treated samples were not different from those of the control samples treated with media alone (Fig. 8) . 
Discussion
This study demonstrates that IL-2 has a stimulatory effect on endothelial cell PGI2 synthesis. The stimulatory activity does not start until the cells have been treated with IL-2 for at least 2 h, and the effect is sustained over a prolonged period of time. This stimulatory pattern is in striking contrast to that exerted by agonists such as ionophore A23187 and bradykinin (22) . These agonists induce a rapid release of AA leading to PGI2 and other eicosanoid synthesis usually within minutes after their addition to the cells. PGI2 production reaches its peak at 30 min and declines thereafter (22) . The self-limitation of PGI2 synthesis stimulated by these agonists is thought to be due to autoinactivation of the cyclooxygenase activity of the PGH synthase molecule (19, 20) . The autoinactivation process is rapid and irreversible. As these agonists are incapable ofstimu--IL-2 kD Cl Y7 (23) and is quite susceptible to cycloheximide treatment. Third, we have previously shown that IL-2 is capable of stimulating aspirin-treated EC to convert exogenous AA into PGI2 2-3 h after aspirin treatment, while the control cells remain unable to metabolize exogenously added AA into eicosanoids even at 24 h after the addition of aspirin (1 1). The time course for converting AA eicosanoid production in the aspirin-treated cells after IL-2 induction showed a sustained increment in PG12 synthesis (1 1). Taken together, these findings provide convincing evidence that IL-2 enhances PGI2 synthesis in endothelial cells via induction of de novo synthesis of PGH synthase. Our study reveals a major difference between endothelial cells and lymphocytes in response to rIL-2 stimulation. Substitution of rIL-2 Cys'25 has no demonstrable influence on its ability to stimulate lymphocyte thymidine incorporation. Using site-directed mutagenesis, Ju et al. have provided a valuable structure-function analysis of human IL-2 (24). Site-directed mutagenesis of the cysteine residues indicates that the cysteines at positions 58 and 105 must be maintained for rIL-2 bioactivity, while a substitution at Cys'25 has no drastic effects. They postulated that Cys58 and Cys'05 form an intramolecular disulfide bond that stabilizes the IL-2 molecule in the bioactive conformation. By contrast, Cys'25 is critical for maintaining the bioactivity of rIL-2 toward cultured endothelial cells. Substitution of Cys125 with alanine or serine leads to a drastic reduction of its PGI2-stimulating activity. The alanine-substituted rIL-2 failed to enhance the PGH synthase band on the Western blot. By inference, our data imply that the contact site of rIL-2 with endothelial cell IL-2 receptors requires Cys125 to maintain its bioactive conformation. BAECS produce a much higher quantity of PGI2 than HUVECS when stimulated with human IL-2. This may reflect a species difference in IL-2 receptor interaction with its ligand.
Endothelial cells synthesize and release a number of proteins important in modulating platelet and vascular reactivity. Since IL-2 stimulates PGI2 production via an increase in PGH synthase, we reasoned that it might exert an influence on the production of other physiologically important proteins. We chose to measure the release of two such proteins. vWf is a multimeric adhesive protein that mediates the adhesion of platelets to denuded vessel wall (25). tPA converts plasminogen into plasmin which is pivotal for lysing fibrin clots (26) . Both proteins can be accurately measured by ELISA with monoclonal antibodies. While rIL-2 induces a steady increase of PGI2 production in the culture medium, it has little effect on vWf or tPA production. The 
